FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Nomax Dry Eye Test Recall

Dry Eye Test, Fluorescein Sodium, Ophthalmic Strips USP (0

Nomax Inc · Saint Louis, MO

Risk level
Class III
Reported by FDA
May 26, 2021
Recall ID
D-0387-2021
Check your lot numberHow we source this data

Summary

Nomax recalled Dry Eye Test starting Apr 13, 2021. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-0387-2021 on May 26, 2021. Reason: Subpotent Drug. Status: Terminated.

Why it was recalled

Subpotent Drug

Product description

Dry Eye Test, Fluorescein Sodium, Ophthalmic Strips USP (0.12mg Fluorescein Sodium), 100 Sterile Strips (50 Pouches of 2 Strips Each), Manufactured by: Nomax, Inc, St. Louis, MO 63123, NDC: 51801-008-15

Lot numbers, UPCs & expiration codes

LOT 13336 EXP 07/23

Where it was sold

Nationwide USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0387-2021
Classification
Class III
Status
Terminated
Recall initiated
Apr 13, 2021
FDA report date
May 26, 2021
Quantity
78 cartons
Recall type
Voluntary: Firm initiated
Recalling firm
Nomax Inc

Original FDA data

Every field from FDA enforcement report D-0387-2021, exactly as published.

Show all FDA fields
City
Saint Louis
State
MO
Status
Terminated
Country
United States
Event ID
87695
Address
9735 Green Park Industrial Dr
Code information
LOT 13336 EXP 07/23
Postal code
63123-7241
Report date
May 26, 2021
Product type
Drugs
Recall number
D-0387-2021
Classification
Class III
Recalling firm
Nomax Inc
Product quantity
78 cartons
Termination date
Sep 28, 2023
Reason for recall
Subpotent Drug
Voluntary / mandated
Voluntary: Firm initiated
Product description
Dry Eye Test, Fluorescein Sodium, Ophthalmic Strips USP (0.12mg Fluorescein Sodium), 100 Sterile Strips (50 Pouches of 2 Strips Each), Manufactured by: Nomax, Inc, St. Louis, MO 63123, NDC: 51801-008-15
Distribution pattern
Nationwide USA
Recall initiation date
Apr 13, 2021
Initial firm notification
Letter
Center classification date
May 18, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0387-2021, published May 26, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls